CARB-X: A US-based nonprofit developing antibacterial pharmaceuticals to combat bacterial threats.
Founded
2016
Location
Boston, MA, US
Founded as a nonprofit partnership, CARB-X focuses on accelerating global antibacterial innovation to combat drug-resistant bacterial threats. Their core mission is to support the development of new antibiotics, vaccines, rapid diagnostics, and other life-saving products. CARB-X aims to protect humanity from the most dangerous bacterial infections through a scientifically diverse portfolio of early development projects.
Notable affiliates include leading experts in microbiology and public health, with significant funding from major global health organizations. CARB-X has invested millions in innovative antibacterial solutions, contributing to a robust pipeline of potential treatments. Their impact is evident in the advancement of critical antibacterial products, addressing a significant public health challenge worldwide.
